Kiora Pharmaceuticals KPRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 2.78 | 128.90 | 0.06 | -794 | 0 | |
| 2025Q2 | 2.88 | 105.83 | -0.54 | -2,396 | -2 | |
| 2025Q1 | 3.01 | 112.56 | 2.51 | -0.52 | -2,330 | -2 |
| 2024Q4 | 3.30 | 120.03 | 2.76 | -1.04 | -2,565 | -4 |
| 2024Q3 | 3.66 | 105.54 | 1.96 | -0.88 | -3,602 | -3 |
| 2024Q2 | 4.20 | 114.54 | 5.48 | -0.67 | -2,545 | -2 |
| 2024Q1 | 6.35 | 98.28 | 3.46 | 13,222 | 13 | |
| 2023Q4 | 4.70 | 97.74 | -0.90 | -2,119 | -2 | |
| 2023Q3 | 5.11 | 102.71 | -7.72 | -5,919 | -6 | |
| 2023Q2 | 5.79 | 100.73 | -6.63 | -2,633 | -3 | |
| 2023Q1 | 30.06 | 102.57 | -9.00 | -1,917 | -2 | |
| 2022Q4 | 30.87 | 101.23 | 31.59 | -2,635 | -2 | |
| 2022Q3 | 55.35 | 72.20 | -194.40 | -3,703 | -5 | |
| 2022Q2 | 169.42 | 100.04 | 97.29 | -2,402 | -2 | |
| 2022Q1 | 224.06 | 100.11 | -101.43 | -3,569 | -4 | |
| 2021Q4 | 543.60 | 100.02 | 12334.44 | -6,371 | -6 | |
| 2021Q3 | -12628.93 | -3,464 | -3 | |||
| 2021Q2 | 109.19 | -122.40 | -3,316 | -3 | ||
| 2021Q1 | -97.20 | -2,580 | -3 | |||
| 2020Q4 | 104.75 | -86.40 | -2,513 | -2 |